Strides Pharma Science LtdNSE: STAR

Press Release Nov 18 2022

· Issued by Strides Pharma Science Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-18-2022-10

Strides Pharma Science Limited has informed the Exchange about press release dated 18-Nov-2022 titled Strides receives USFDA approval for Potassium Chloride Oral Solution

View Attachment

6ix hasn’t read this filing yet.

Strides Pharma Science Ltd on 6ix

Earlier from Strides Pharma Science

Later from Strides Pharma Science

All Strides Pharma Science news releases